FDA approves Biogen-Eisai Alzheimer’s drug, China in talks to make Pfizer Paxlovid generic

Pfizer ends research for Alzheimer's, Parkinson's drugs 🇺🇸

Pfizer had clues its drug could prevent Alzheimer’s. What happened?

Pfizer pulls new Alzheimer's research program

What Does Pfizer Backing Out of Alzheimer Research Mean to the Field? | Advances in Dementia Care

Pfizer to stop research for Alzheimer's, Parkinson's drugs

Investigating Potential Therapies for Alzheimer’s

Facing a Father’s Alzheimer’s

Eli Lilly's Alzheimer's drug slows cognitive decline: Study

Pfizer Tackles Devastating Neurological Diseases

That Pricey New Alzheimer's Drug? Still Not Great

Powerful Impact of Medical Research – A Pfizer Colleague’s Story

FDA fast-tracks approval for Alzheimer's drug

Biden Administration Has New Plans For Pfizer’s Antiviral Drug Paxlovid To Treat COVID-19

FDA approves first new Alzheimer's drug in nearly two decades, raising hopes despite skepticism

FDA greenlights new Alzheimer's drug amid safety concerns

FDA approves new drug to slow progression of Alzheimer's

Researching Cures for Alzheimer’s and Other Devastating Diseases -- The Doctors

Singapore involved in study on new drug to slow progression of Alzheimer’s disease | THE BIG STORY

Pfizer’s Legacy and Expertise in Cardiovascular Diseases